Projects
Projects FNS
Histone deacetylase inhibitors and innate immune responses to microbial infections
2006 - 2010
Histone deacetylases as central regulators of innate immunity and potential therapeutic targets for severe sepsis: the role of sirtuins
2010 - 2013
MIF as a regulator of plasmacytoid dendritic cell function
2011 - 2014
Interaction of the T3SSs of Waddlia chondrophila and Parachlamydia acanthamoebae with the NAIP/IPAF inflammasome complex
2012 - 2015
Innate immunogenetic study of invasive aspergillosis in hematopoietic cells transplant recipients
2009 - 2012
Macrophage migration inhibitory factor (MIF) and innate immune response to bacterial infection
2002 - 2007
Macrophage migration inhibitory factor and dendritic cells: bridging innate and adaptive immunity
2007 - 2011
European Programs
HDM-FUN. Host directed medicine in invasive fungal infection
2020 - 2024
H2020-SC1-2019-Two-Stage-RTD [SEP-210574886] HDM-FUN. Host directed medicine in invasive fungal infection.
ImmunoSep. Personalized immuno-therapy in sepsis: a precision medicine based approach
2020 - 2024
H2020-SC1-2019-Two-Stage-RTD [847422-2]. ImmunoSep. Personalized immuno-therapy in sepsis: a precision medicine based approach
European Sepsis Academy: towards new biomarkers to improve sepsis management
2016 - 2020
H2020 Marie Skłodowska -Curie ESA-ITN. #676129. European Sepsis Academy: towards new biomarkers to improve sepsis management
Fungi in the setting of inflammation, allergy and autoimmune diseases: translating basic science into clinical practice
2010 - 2013
Others projects
Poxvirus T-cell vaccine discovery consortium
2006 - 2010
grant-giving organisation : Bill & Melinda Gates Foundation: Collaboration for AIDS Vaccine Discovery
Histone deacetylase inhibitors and innate immune responses to microbial infections
2006 - 2006
grant-giving organisation : Merck Sharp & Dohme-Chibret AG
SPHN/PHRT. Personalized Swiss Sepsis Study.
2018 - 2021
Swiss Personalized Health Network/Personalized Health and Related Technologies. Personalized Swiss Sepsis Study. Detection and modelling of sepsis using machine learning to monitor ICU patients, laboratory and microbiology data in real time in parallel with omics studies for personalized sepsis management.
Immunomodulation of innate immune responses for the treatment of sepsis
2009 - 2010
grant-giving organisation : Swiss Society for Infectious Diseases
Immune response to a combine exposure of microbial compounds: assessment of occupational health risk to complex bioaerosols
2012 - 2015
grant-giving organisation : FBM, Interdisciplinary Grant
Macrophage migration inhibitory factor: gene polymorphism and innate immune response to bacterial infection
2002 - 2005
grant-giving organisation : Leenaards Foundation
Registered Patents
TLR4 and MIF in the treatment of septic shock
60/216,584 and 60/274,004
US Provisional Patent 60/216,584 (07/2000) and US Provisional patent 60/274,004 (03/2001)
Owner : Roger T, Glauser MP, Calandra T
08.03.2001
U.S.A.
Methods for regulation of immune responses to conditions involving mediator-induced pathology
20349-520/IDF 10/00
Owner : Roger T, David J, Glauser MP and Calandra T
08.10.2000
U.S.A.
Modified Immunization Vectors
61174024
Owner : Joint patent by members of the Poxvirus T-Cell Vaccine Discovery Consortium (PTVDC): CHUV, Lausanne; Consejo Superior de Investigaciones Cientificas, Madrid; Arizona State University, Tempe; Academisch Ziekenhuis Leiden, Leiden; Université de Montréal, Mo
08.04.2009
U.S.A.
